Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 452
Selected: 0
NCT IDTitle
NCT06245941A Clinical Trial of TQ05105 Tablets Combined With TQB3909 Tablets in the Treatment of Myelofibrosis (MF)
NCT05828953Anlotinib Capsules in the Treatment for IPF/PF-ILDs
NCT06900920A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia
NCT05451407Efficacy and Safety of TQB2618 Injection Combined With Toripalimab Injection in Patients With Advanced Melanoma
NCT05001971Anlotinib Plus Penpulimab as Second-line Treatment for Patients With Small Cell Lung Cancer After Failure of Platinum-based Chemotherapy
NCT03799601Docetaxel Combined With Carboplatin Plus Anlotinib as First Line Treatment in NSCLC
NCT04203719A Study of Anlotinib and AK105 Injection in Subjects With Advanced Head, Neck and Chest Cancer
NCT02734966Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver Injury
NCT06160895A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects
NCT05994365Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma
NCT06561607A Clinical Trial to Evaluate the Efficacy and Safety of TQB2102 for Injection Versus Investigator-Selected Chemotherapy in HER2 Low-Expressing Recurrent/Metastatic Breast Cancer
NCT05913089A Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer
NCT06550713A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies
NCT05866510Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal Cancer
NCT04275050A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3303 Tablets
NCT06738979A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects
NCT05807880Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT07538973A Clinical Study to Evaluate the Pharmacokinetics and Safety of Anecatibin Fumarate Capsules in Subjects With Impaired Liver Function Versus Normal Liver Function
NCT05800106A Bioequivalence Study of Sunitinib Malate Capsules.
NCT04073537Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy in Subjects With Squamous Non-small Cell Lung Cancer
NCT05192512Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers
NCT04273815A Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets
NCT05735496Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers
NCT05859373To Evaluate the Efficacy and Safety of TQB3728 Tablets in Sequential Maintenance of TQB2450 Injection Therapy in Patients After Sequential or Concurrent Chemoradiation for Locally Advanced Non-small Cell Lung Cancer.
NCT07501169Sacituzumab Tirumotecan in Combination With Anlotinib in Previously Treated Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
NCT07291050A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3217 Tablets in Subjects With Advanced Malignant Tumors
NCT06496490A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality
NCT07663526Treatment of Chinese Adult Subjects With Moderate to Severe Crohn's Disease With Tabellvi®
NCT03624309Anlotinib Plus Docetaxel for the Treatment of EGFR Wild-type Advanced Non-small-cell Lung Cancer
NCT03457844A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3
NCT07622667Correlation Analysis of Gene Characteristics of Malignant Tumors With Prognosis
NCT04373967Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes
NCT01806376A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics
NCT02332499Study of Anlotinib in Patients With Metastatic Colorectal Cancer(mCRC)(ALTER0703)
NCT04975204A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors
NCT05745363Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer
NCT06566248A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis B
NCT01846650A Bioequivalence Study of Capecitabine Tablets
NCT07156643A Prospective, Single-arm, Multicenter Exploratory Clinical Study of Anlotinib Combined With Bempegaldesleukin and Conventional Chemoradiotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Soft Tissue Sarcoma.
NCT01795716Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body
NCT04569838A Study to Evaluate the Efficacy and Safety of Bendamustine Hydrochloride Injection
NCT07400406A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance for the Detection of Calcified Coronary Arteries
NCT03998085Anlotinib Single Drug as the Maintenance Treatment for Advanced NSCLC
NCT06429397Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma
NCT01886053A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia
NCT05862337Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.
NCT05405439To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate Cancer
NCT06222944Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA
NCT05198531To Evaluate the Safety and Efficacy of TQB2858 Injection to the Subjects With Recurrent/Metastatic Nasopharyngeal Cancer
NCT04675060Effect of High-fat Meal on the Pharmacokinetics of TQ-B3139 Capsules